By M.D. Kittle
MADISON — Should life-saving COVID-19 drugs be provided based on race?
The Biden administration thinks so.
And now health care systems reportedly are beginning to follow such “equitable” guidance to the letter, making race and ethnicity a primary factor in determining who receives life-saving COVID-19 treatments such as monoclonal antibodies and oral antiviral drugs.
The Wisconsin Institute for Law & Liberty today sent a letter warning St. Louis-based SSM Health that its risk scoring calculator that prioritizes COVID treatments for “non-white or Hispanic” COVID patients is wrong on many counts.
Continue Reading on Wisconsin Spotlight
